CN108721389A - A kind of product of improvement and treatment thrombopenia - Google Patents
A kind of product of improvement and treatment thrombopenia Download PDFInfo
- Publication number
- CN108721389A CN108721389A CN201710726767.6A CN201710726767A CN108721389A CN 108721389 A CN108721389 A CN 108721389A CN 201710726767 A CN201710726767 A CN 201710726767A CN 108721389 A CN108721389 A CN 108721389A
- Authority
- CN
- China
- Prior art keywords
- improvement
- product
- treatment
- platelet
- thrombocytopenic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
Abstract
Denomination of invention：A kind of product of improvement and treatment thrombopenia（Tablet and granule can be made）.Technical field:The present invention relates to medical medical field, the product formula and preparation method thereof of especially a kind of improvement and treatment thrombopenia.Technical solution：The product is herbal prescription, and prescription science refines, and preparation process is simple.It effectively can quickly improve and be promoted the quantity of human body platelet, while remove vivotoxin, increase immunity, reduce thrombocytopenic disease risks.Main application：The invention is widely used in the improvement and treatment of thrombocytopenic disease, is especially become apparent to thrombocytopenic purpura and varicella effect；It can reach the effect of radical cure.
Description
Technical field
The present invention relates to product formula and medical field, the product of especially a kind of improvement and treatment thrombopenia is matched
Side and preparation method thereof.
Background technology
Decrease of platelet refers to platelet count in blood<100×109/L.Decrease of platelet sees a variety of blood borne diseases
Disease, the damage of rheumatism immunological disease, chemicotherapy and drug-associated decrease of platelet.It may occur in which that difference is faced according to decrease of platelet degree
Bed performance：Less serious case can have dermatorrhagia point, ecchymosis, Gingival blood oozing, nosebleed epistaxis, severe one to can behave as internal organs bleeding：Such as spitting blood, black
Just, blood urine and cerebral hemorrhage etc..
Decrease of platelet major embodiment form is more, clinical " thrombocytopenic purpura " and " thrombocytopenic varicella "
It is more common.The reason of decrease of platelet, mainly has：
（One）Thrombocytopoiesis is less：Heredity such as Fanconi anaemias, congenital companion's deformity subtracts without megacaryocyte blood platelet
Few disease and May-Hegglin are abnormal etc..Acquired aplastic anemia, bone marrow infiltration（The transfer of malignant tumour marrow, white blood
Disease, myelofibrosis, tuberculosis）, chemotherapeutics, radiation, megacaryocyte aregeneratory, virus infection（Measles, the popular parotid gland
It is scorching）, influence thrombopoietic drug（Such as alcohol）, vitamin B12, folic acid deficiency.
（Two）Platelet destruction caused by nonimmunologic factor increases：Thrombotic thrombocytopenic purpura, gestation, infection,
Hemangioma-thrombocytopenia syndrome, snake bite, acute respiratory distress syndrome, serious burn etc..
（Three）Platelet destruction caused by immune factor increases：Immunologic thrombocytopenic purpura, HIV infection, period
Property decrease of platelet, drug-induced decrease of platelet（Heparin, quinine, quinindium, analgesic-antipyretic, penicillin, cephalo-type are anti-
Raw element, rifampin, frusemide, carbamazepine, sodium vedproate, sulfonylureas drugs for diabetes and dilantin sodium etc.）, blood platelet subtracts after blood transfusion
It is few.
（Four）Blood platelet abnormal distribution：Hypersplenia, cooling.
（Five）Blood platelet is lost：Bleeding, in vitro perfusion, haemodialysis.
（Six）Other：False decrease of platelet.
Decrease of platelet clinically also can be rated as the disease of difficulty.The major function of blood platelet is exactly the work of hemostasis and blood coagulation
With.Decrease of platelet, hemostasis and coagulation function will weaken or cause many hemorrhagic diseases.Decrease of platelet can cause：It is more
Hair property ecchymosis is most commonly in shank;Or occurred small being dispersed in property ecchymosis by the position of microtrauma;Mucosal bleeding (nosebleed,
Gastrointestinal tract and urogenital tract and colporrhagia), and operation after bleed profusely, gastrointestinal tract bleed profusely in central nervous system
Bleeding can threat to life.
According to statistics according to imperfect number, it is more with young women, man, female's incidence are 1：3~4.The morbidity of this disease is poor without region
Not, incidence is about 1/20000, is more common in children and person between twenty and fifty, accounts within 30 years old or less 60%-76%, is no more than 10% within 40 years old or more.
Greatly harm will also result on people's lives and work and influence.Clinic is more more with thrombocytopenic purpura and varicella
See.
Clinically general treatment means are to increase platelet counts with drug to decrease of platelet, but blood platelet after being discontinued
Quantity can be reduced again.So there are still defects for improvement and treatment thrombocytopenic disease in the world, subtract in treatment blood platelet
The medical field of few property disease also has great development space, needs new research and discovery to make up the sky of this medical field
It lacks.And the product that my company is developed can effectively improve and treat part disease caused by decrease of platelet.Especially small with blood
Plate reduction property purpura and varicella are more preferably.The demand in International Medical and market is catered to completely.
Invention content
The object of the present invention is to provide a kind of products can effectively improve and treat thrombocytopenic disease.With improvement
With the function for the treatment of thrombocytopenic disease.To compensate for the defect for treating thrombocytopenic disease in the world.
In order to achieve the above objectives, formula composition and deal of the invention：10-15 parts of radix scutellariae of 1-20 parts of rheum officinale campanulaceae 1-10
1-50 parts of Radix Glycyrrhizae of 1-20 portions of gypsum
A kind of product of improvement and treatment thrombopenia, preparation method are：Attritive powder is made in above-mentioned raw materials rheum officinale,
After remaining medicine extraction concentration, the drying of rheum officinale fine powder mixing, preparations shaping is added.
Advantageous effect
The product of a kind of improvement and treatment thrombopenia of the present invention, caused by can be widely applied to decrease of platelet
Disease, emphasis apply to the less property purpura of blood platelet and varicella.
The product of a kind of improvement and treatment thrombopenia of the present invention, the refining of prescription science, preparation process
Simply, the quantity of human body platelet is can effectively improve, body immunity is increased, reduces thrombocytopenic disease risks.Safety
Property it is high, have no toxic side effect.
Specific implementation mode
A kind of the product prescription and deal of improvement and treatment thrombopenia：20 parts of rheum officinale, 10 parts of radix scutellariae, campanulaceae 10
Part, 15 parts of gypsum, 5 parts of Radix Glycyrrhizae.
A kind of product preparation method of improvement and treatment thrombopenia, takes out rheum officinale and attritive powder is made, remaining medicine carries
After taking concentration, after the drying of rheum officinale fine powder mixing is added, whether sampling check component content ratio is consistent, after ratio is consistent.It carries out
Piece forming or shaping particles can be pressed into.Occur with tablet or granule.Carry out least unit semi finished package, carry out at
Product are packed, and end product sterilization treatment is product.
Claims (2)
1. the product of a kind of improvement and treatment thrombopenia.
2. it is characterized in that formula composition and deal：1-20 portions of rheum officinale 10-15 parts of radix scutellariae campanulaceae 1-20 portions of Radix Glycyrrhizaes of 1-10 gypsum
1-50 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710726767.6A CN108721389A (en) | 2017-08-23 | 2017-08-23 | A kind of product of improvement and treatment thrombopenia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710726767.6A CN108721389A (en) | 2017-08-23 | 2017-08-23 | A kind of product of improvement and treatment thrombopenia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108721389A true CN108721389A (en) | 2018-11-02 |
Family
ID=63940362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710726767.6A Pending CN108721389A (en) | 2017-08-23 | 2017-08-23 | A kind of product of improvement and treatment thrombopenia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108721389A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102727664A (en) * | 2012-05-31 | 2012-10-17 | 固镇县中医院 | Chinese herbal preparation for treating thrombocytopenia |
-
2017
- 2017-08-23 CN CN201710726767.6A patent/CN108721389A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102727664A (en) * | 2012-05-31 | 2012-10-17 | 固镇县中医院 | Chinese herbal preparation for treating thrombocytopenia |
Non-Patent Citations (1)
| Title |
|---|
| 张烨雯等: "皮肤病验案4则", 《吉林中医药》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107158063B (en) | Enteric-coated pellet prepared from honeysuckle effective part composition and preparation method thereof | |
| TWI733987B (en) | Powder having function on improving immunity and the preparation method thereof | |
| JP5577129B2 (en) | Liver function improving agent in patients with viral hepatitis | |
| JP2013194036A (en) | Pharmaceutical composition | |
| CN100340235C (en) | Montmorillonite dispersed tablet and preparation technique thereof | |
| WO2015024218A1 (en) | Pharmaceutical composition, preparation method therefor and use thereof | |
| CN104721156A (en) | Rivaroxaban-containing tablets | |
| CN104224858B (en) | Cordyceps militaris microcapsules, preparation and preparation method thereof | |
| CN108721389A (en) | A kind of product of improvement and treatment thrombopenia | |
| CN104288164B (en) | Pharmaceutical composition for preventing acute alcoholic liver injury | |
| CN1965951A (en) | Blood tonic capsule having ass hide and method for preparing same | |
| CN102895264B (en) | Red nocardia rubra cell wall skeleton buccal tablet and preparation method thereof | |
| WO2009000150A1 (en) | The use of sanchinoside in treating septicemia | |
| CN104606226B (en) | Anti-inflammation Chinese medicine suppository and preparation method thereof and quality control method | |
| KR101497508B1 (en) | Solid preparations containing Pelargonium sidoides extracts and silicic acid compound, and preparing method thereof | |
| WO2017129060A1 (en) | Medicine used for treating influenza, upper respiratory tract infection, viral pneumonia | |
| CN107536921B (en) | Traditional Chinese medicine composition for treating hyperlipoproteinemia and application thereof | |
| CN1759871A (en) | Hemostasis capsule and preparation technique | |
| CN104587300A (en) | Traditional Chinese medicine composition for treating acute leukemia and preparation method of traditional Chinese medicine composition | |
| CN103156878A (en) | Phellinus baumii polysaccharide and OPC (Oligomeric Proantho Cyanidins) slow-release micro-capsules | |
| CN108114309A (en) | A kind of aldehydedodextrans/montmorillonite Composite rapid hemostatic material and preparation method thereof | |
| CN100340232C (en) | Jinshu leaf styptic mixture and its preparing method and use | |
| CN102743758B (en) | Moisture protection method of traditional Chinese medicine extract and solid preparation obtained by traditional Chinese medicine | |
| CN103536563A (en) | Levorotatory-pantoprazole sodium composition freeze-dried powder for injection | |
| JP7114227B2 (en) | Tablets containing Seihaito extract powder |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20181102 |
|
| WD01 | Invention patent application deemed withdrawn after publication |